anti-alpha-synuclein monoclonal antibodies for prevention of tau aggregation

摘要

Anti-Alpha-Synuclein Monoclonal Antibodies to Prevent Aggregation of Tau The invention relates to a novel use of anti-alpha-synuclein monoclonal antibodies. Antibodies can be used to prevent tau aggregation and thereby treat tauopathies such as alzheimer's disease.